Moberg Pharma AB (publ): cash_and_equivalents

Value{"amount": 293289000.0, "concept": "ifrs-full:CashAndCashEquivalents"}
Period (as of 2024-12-31)
Statuscurrent
EntityMoberg Pharma AB (publ)
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference: esef:549300XFXK7DVGDRP410:2024-12-31
Retrieved: 2026-08-23T23:10:07.486177+02:00
Raw response sha256: 5630484fae85df0a119159b0aec6290e…
Cite as: FACTANKER, https://factanker.com/fact/94c279b6-e13d-4f60-a73c-31b0aa2ed3b3

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies